advertisement
Tang J 21
Showing records 1 to 21 | Display all abstracts from Tang J106511 Comparison of efficacy and safety of intravitreal ranibizumab and conbercept before vitrectomy in Chinese proliferative diabetic retinopathy patients: a prospective randomized controlled trial
Li S
Eye and vision (London, England) 2022; 9: 44
105779 Ionic Liquid Pilocarpine Analog as an Antiglaucoma Drug Candidate
Wang J
ACS pharmacology & translational science 2022; 5: 752-760
106154 Increased Mobile Zinc Regulates Retinal Ganglion Cell Survival via Activating Mitochondrial OMA1 and Integrated Stress Response
Tang J
Antioxidants (Basel, Switzerland) 2022; 11:
106511 Comparison of efficacy and safety of intravitreal ranibizumab and conbercept before vitrectomy in Chinese proliferative diabetic retinopathy patients: a prospective randomized controlled trial
Guo L
Eye and vision (London, England) 2022; 9: 44
105779 Ionic Liquid Pilocarpine Analog as an Antiglaucoma Drug Candidate
Li B
ACS pharmacology & translational science 2022; 5: 752-760
106154 Increased Mobile Zinc Regulates Retinal Ganglion Cell Survival via Activating Mitochondrial OMA1 and Integrated Stress Response
Liu Z
Antioxidants (Basel, Switzerland) 2022; 11:
106511 Comparison of efficacy and safety of intravitreal ranibizumab and conbercept before vitrectomy in Chinese proliferative diabetic retinopathy patients: a prospective randomized controlled trial
Zhou P
Eye and vision (London, England) 2022; 9: 44
106154 Increased Mobile Zinc Regulates Retinal Ganglion Cell Survival via Activating Mitochondrial OMA1 and Integrated Stress Response
Han J
Antioxidants (Basel, Switzerland) 2022; 11:
105779 Ionic Liquid Pilocarpine Analog as an Antiglaucoma Drug Candidate
Tang J; Qiu L
ACS pharmacology & translational science 2022; 5: 752-760
106511 Comparison of efficacy and safety of intravitreal ranibizumab and conbercept before vitrectomy in Chinese proliferative diabetic retinopathy patients: a prospective randomized controlled trial
Tang J
Eye and vision (London, England) 2022; 9: 44
106154 Increased Mobile Zinc Regulates Retinal Ganglion Cell Survival via Activating Mitochondrial OMA1 and Integrated Stress Response
Xue J
Antioxidants (Basel, Switzerland) 2022; 11:
106511 Comparison of efficacy and safety of intravitreal ranibizumab and conbercept before vitrectomy in Chinese proliferative diabetic retinopathy patients: a prospective randomized controlled trial
Wang Z
Eye and vision (London, England) 2022; 9: 44
105779 Ionic Liquid Pilocarpine Analog as an Antiglaucoma Drug Candidate
Qiao X
ACS pharmacology & translational science 2022; 5: 752-760
106154 Increased Mobile Zinc Regulates Retinal Ganglion Cell Survival via Activating Mitochondrial OMA1 and Integrated Stress Response
Liu L; Lin J
Antioxidants (Basel, Switzerland) 2022; 11:
105779 Ionic Liquid Pilocarpine Analog as an Antiglaucoma Drug Candidate
Xu N
ACS pharmacology & translational science 2022; 5: 752-760
106511 Comparison of efficacy and safety of intravitreal ranibizumab and conbercept before vitrectomy in Chinese proliferative diabetic retinopathy patients: a prospective randomized controlled trial
Zhang L
Eye and vision (London, England) 2022; 9: 44
105779 Ionic Liquid Pilocarpine Analog as an Antiglaucoma Drug Candidate
Yang H
ACS pharmacology & translational science 2022; 5: 752-760
106511 Comparison of efficacy and safety of intravitreal ranibizumab and conbercept before vitrectomy in Chinese proliferative diabetic retinopathy patients: a prospective randomized controlled trial
Zhao M
Eye and vision (London, England) 2022; 9: 44
106154 Increased Mobile Zinc Regulates Retinal Ganglion Cell Survival via Activating Mitochondrial OMA1 and Integrated Stress Response
Wu C
Antioxidants (Basel, Switzerland) 2022; 11:
106511 Comparison of efficacy and safety of intravitreal ranibizumab and conbercept before vitrectomy in Chinese proliferative diabetic retinopathy patients: a prospective randomized controlled trial
Qu J
Eye and vision (London, England) 2022; 9: 44
106154 Increased Mobile Zinc Regulates Retinal Ganglion Cell Survival via Activating Mitochondrial OMA1 and Integrated Stress Response
Zhang Q; Wu S; Liu C; Huang H; Fu Y; Li M; Zhuo Y; Li Y
Antioxidants (Basel, Switzerland) 2022; 11:
